These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37875818)

  • 1. Construction of a comprehensive predictive model for axillary lymph node metastasis in breast cancer: a retrospective study.
    Li Y; Han D; Shen C; Duan X
    BMC Cancer; 2023 Oct; 23(1):1028. PubMed ID: 37875818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the axillary lymph-node metastatic burden of breast cancer by
    Li Y; Han D; Shen C
    BMC Cancer; 2024 Jun; 24(1):704. PubMed ID: 38849770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
    Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
    Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative prediction of lymph node metastasis in colorectal cancer using
    Wang Y; Zhao H; Fu P; Tian L; Su Y; Lyu Z; Gu W; Wang Y; Liu S; Wang X; Zheng H; Du J; Zhang R
    Med Phys; 2024 Aug; 51(8):5214-5225. PubMed ID: 38801340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC.
    Wang M; Liu L; Dai Q; Jin M; Huang G
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):247-261. PubMed ID: 36565319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the accuracy of
    Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
    Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cutting-edge deep learning-and-radiomics-based ultrasound nomogram for precise prediction of axillary lymph node metastasis in breast cancer patients ≥ 75 years.
    Qian L; Liu X; Zhou S; Zhi W; Zhang K; Li H; Li J; Chang C
    Front Endocrinol (Lausanne); 2024; 15():1323452. PubMed ID: 39072273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant results in
    Parisse-Di Martino S; Faure C; Mognetti T
    Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning Model for Predicting Axillary Lymph Node Metastasis in Clinically Node Positive Breast Cancer Based on Peritumoral Ultrasound Radiomics and SHAP Feature Analysis.
    Wang SR; Cao CL; Du TT; Wang JL; Li J; Li WX; Chen M
    J Ultrasound Med; 2024 Sep; 43(9):1611-1625. PubMed ID: 38808580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental value of PET primary lesion-based radiomics signature to conventional metabolic parameters and traditional risk factors for preoperative prediction of lymph node metastases in gastric cancer.
    Xue XQ; Yu WJ; Shao XL; Wang YT
    Abdom Radiol (NY); 2023 Feb; 48(2):510-518. PubMed ID: 36418614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
    Riegger C; Koeninger A; Hartung V; Otterbach F; Kimmig R; Forsting M; Bockisch A; Antoch G; Heusner TA
    Acta Radiol; 2012 Dec; 53(10):1092-8. PubMed ID: 23002144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
    Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
    Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer.
    Song BI
    Breast Cancer; 2021 May; 28(3):664-671. PubMed ID: 33454875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using ultrasound features and radiomics analysis to predict lymph node metastasis in patients with thyroid cancer.
    Li F; Pan D; He Y; Wu Y; Peng J; Li J; Wang Y; Yang H; Chen J
    BMC Surg; 2020 Dec; 20(1):315. PubMed ID: 33276765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of
    Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
    Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep-learning features based on F18 fluorodeoxyglucose positron emission tomography/computed tomography (
    Wang H; Zhang J; Li Y; Wang D; Zhang T; Yang F; Li Y; Zhang Y; Yang L; Li P
    Clin Radiol; 2024 Sep; 79(9):e1152-e1158. PubMed ID: 38955636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
    Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
    Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
    Anticancer Res; 2016 Jan; 36(1):393-7. PubMed ID: 26722071
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
    Front Oncol; 2022; 12():911168. PubMed ID: 36003788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.